XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $320 | -99.9% | 9,371 | -6.2% | 0.03% | -11.1% |
Q3 2022 | $361,000 | -15.7% | 9,990 | -28.6% | 0.04% | -28.0% |
Q1 2022 | $428,000 | +177.9% | 13,993 | +3.4% | 0.05% | +66.7% |
Q1 2020 | $154,000 | +275.6% | 13,539 | +4.1% | 0.03% | +275.0% |
Q2 2017 | $41,000 | – | 13,001 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 467,368 | $7,188,000 | 3.91% |
Ghost Tree Capital, LLC | 700,000 | $10,766,000 | 2.40% |
BVF INC/IL | 3,499,346 | $53,820,000 | 2.12% |
DAFNA Capital Management LLC | 346,535 | $5,330,000 | 1.59% |
Parkman Healthcare Partners LLC | 361,689 | $5,563,000 | 1.42% |
KNOTT DAVID M | 200,000 | $3,076,000 | 1.39% |
Soleus Capital Management, L.P. | 558,117 | $8,584,000 | 1.13% |
Avoro Capital Advisors LLC | 2,800,000 | $43,064,000 | 0.74% |
NEA Management Company, LLC | 992,107 | $15,259,000 | 0.40% |
Orbimed Advisors | 2,497,917 | $38,418,000 | 0.34% |